Eureka Biotech Call 2026

6 May – 25 Sept 2026

Register
Register
Register

Project cooperationUpdated on 15 June 2026

Ex vivo CAR-T treatment

Head of strategy at VIROXIS

PARIS, France

About

Viroxis, in collaboration with Institut Gustave Roussy, has developed and optimized a new CAR-T cells preparation process, without the standard activation which leads to exhaustion. We are looking for development partners

Stage

  • Design - setting the project scope

Topic

  • Next-generation therapeutics and modalities

Type

  • Expertise offered

Organisation

VIROXIS

Start-up

NEUILLY SUR SEINE, France

Similar opportunities